ARDT Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 3.51%, SMA50 5.97%, SMA200 -19.68%). The stock’s 14-day RSI is 55.41 (neutral), while the ATR of 0.34 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -39.19% below its high and over 17.47% above its low. Average 10-day trading volume of 1.01 million shares is significantly above the 3-month average of 428.02 thousand, indicating heightened recent market interest.

Ardent Health Partners, LLC has 143.35 million shares outstanding. The public float is 24.17 million shares, elevated short interest at 8.65% of float. This equals 2.88 million shares. The short ratio is 6.98 days. Institutional investors hold 97.71% of the float. Insiders own 23.11%.

Wall Street analysts project EPS growth of -2.16% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 7 Strong Buy ratings, 5 Buy ratings, 5 Hold ratings, 0 Sell rating and 2 Strong Sell ratings. Price targets range from $20.00 to $10.00. The high target offers 126.5% upside. The low target suggests 13.25% downside. The mean target is $15.03. This offers 70.22% upside. Ardent Health Partners, LLC earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 05, 2026, missed forecasts by 55.56%. The prior quarter beat by -8.05%. Over the last six quarters, Apple has recorded several small beats. These include 62.0% in February 26, 2025.

Ardent Health Partners, LLC last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $10.00. This means the shares are trading below this model’s fair value.

Ardent Health Partners, LLC (NYSE:ARDT) closed at $8.83 USD, gaining $0.15 (1.73%) from the previous close of $8.68. The stock is currently mid-range between its 52-week high and low $7.71 and $15.48. With a market capitalization of about $1.27 billion, Ardent Health Partners, LLC is classified as a small-cap and shows market-like volatility (beta ~0.84). Key stats such as the average daily volume over the past year has been around 431.57 thousand shares, trading with heavier-than-usual volume. Headquartered in Brentwood, TN, Ardent Health Partners, LLC operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Martin J. Bonick, the company employs approximately 19,200 people and listed since July 18, 2024. Operating a vast network of hospitals and clinics throughout the United States, Ardent Health Partners, LLC delivers a diverse array of healthcare services.

Ardent Health Partners, LLC trades at a P/E ratio of 9.12, slightly below the S&P 500 average, with a price-to-sales ratio of 0.19 and a price-to-book ratio of 0.71 suggesting the stock is closer to book value. The P/FCF stands at 5.81, also above market averages.

Our AI price prediction model suggests that Ardent Health Partners, LLC stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.53%, with price expected at $7.90 by June 22, 2026, within a range of $7.57 to $8.21 3-Month Outlook: Projected rise of 13.93%, reaching $10.06 by September 04, 2026, with a range of $9.75 to $10.36. 1-Year Outlook: Projected gain of 104.87%, with price at $18.09 by June 08, 2027, within a range of $12.82 to $23.33.

Ardent Health Partners, LLC (NYSE:ARDT) shares are flat -6.0% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Ardent Health Partners, LLC trading at a premium to the broader market with a P/E of 9.12. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $17.72, suggesting 100.68% upside. Our AI forecast model points to short-term weakness (-10.53% over two weeks), a medium-term rise (13.93% over three months), and a longer-term gain (104.87% over one year), with expected trading ranges indicating moderate volatility.